Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.
- Published In:
- Journal of psychiatric research, 98, 64-69 (2018)
- Authors:
- Flanagan, Julianne C, Sippel, Lauren M, Wahlquist, Amy, Moran-Santa Maria, Megan M, Back, Sudie E
- Database ID:
- RPEP-03669
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03669APA
Flanagan, Julianne C; Sippel, Lauren M; Wahlquist, Amy; Moran-Santa Maria, Megan M; Back, Sudie E. (2018). Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.. Journal of psychiatric research, 98, 64-69. https://doi.org/10.1016/j.jpsychires.2017.12.014
MLA
Flanagan, Julianne C, et al. "Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.." Journal of psychiatric research, 2018. https://doi.org/10.1016/j.jpsychires.2017.12.014
RethinkPeptides
RethinkPeptides Research Database. "Augmenting Prolonged Exposure therapy for PTSD with intranas..." RPEP-03669. Retrieved from https://rethinkpeptides.com/research/flanagan-2018-augmenting-prolonged-exposure-therapy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.